Mark Birkenbach
Impact in
- Immunology top 1%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Psoriasis: Treatment and Pathogenesis
- Immunotherapy and Immune Responses
- Oncology top 1%
- Viral-associated cancers and disorders
Papers in
- Immunology 21
- Immune Cell Function and Interaction 7
- IL-33, ST2, and ILC Pathways 6
- T-cell and B-cell Immunology 5
- Immunotherapy and Immune Responses 4
-
- Lymphoma Diagnosis and Treatment 8
- Co-authors
- Elliott KieffOdile DevergneCaroline AlfieriKnud JosefsenRichard S. BlumbergJeffery T. SampleDaniel BraunGilbert Lenoir
- Journals
- Journal of Virology (6 papers)Proceedings of the National Academy of Sciences (5 papers)Virology (3 papers)The Journal of Experimental Medicine (2 papers)Carcinogenesis (2 papers)
- Partner nations
- United StatesGermanyJapan
In The Last Decade
Mark Birkenbach
53 papers receiving 3.8k citations
Peers
Comparison fields: 5 of 101
- Immunology 1.8k
- Oncology 2.0k
- Pathology and Forensic Medicine 958
- Infectious Diseases 650
- Epidemiology 783
Countries citing papers authored by Mark Birkenbach
This map shows the geographic impact of Mark Birkenbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Birkenbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Birkenbach more than expected).
Fields of papers citing papers by Mark Birkenbach
This network shows the impact of papers produced by Mark Birkenbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Birkenbach. The network helps show where Mark Birkenbach may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Birkenbach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 12 | |
| 2 | 2021 | 121 | |
| 3 | 2021 | 17 | |
| 4 | 2020 | 1 | |
| 5 | 2020 | 9 | |
| 6 | 2017 | 4 | |
| 7 | 2014 | 14 | |
| 8 | 2013 | 11 | |
| 9 | 2013 | 15 | |
| 10 | 2013 | 29 | |
| 11 | Targeting alloantibody production with bortezomib: does it make more sense? | 2010 | 1 |
| 12 | 2007 | 11 | |
| 13 | 2006 | 147 | |
| 14 | 2005 | 130 | |
| 15 | 2005 | 43 | |
| 16 | 2004 | 29 | |
| 17 | 2002 | 151 | |
| 18 | 1999 | 63 | |
| 19 | 1992 | 69 | |
| 20 | 1991 | 239 |
About Mark Birkenbach
Mark Birkenbach is a scholar working on Immunology, Pathology and Forensic Medicine, Oncology, Infectious Diseases and Clinical Biochemistry, having authored 54 papers that have together received 3.9k indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (13 papers), Lymphoma Diagnosis and Treatment (8 papers), Immune Cell Function and Interaction (7 papers), IL-33, ST2, and ILC Pathways (6 papers), Parvovirus B19 Infection Studies (5 papers), T-cell and B-cell Immunology (5 papers), Immunotherapy and Immune Responses (4 papers) and Eosinophilic Disorders and Syndromes (4 papers). The work is most often cited by research in Immunology (1.8k citations), Oncology (2.0k citations), Pathology and Forensic Medicine (958 citations), Infectious Diseases (650 citations) and Epidemiology (783 citations). Mark Birkenbach has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Elliott Kieff, Odile Devergne, Caroline Alfieri, Knud Josefsen, Richard S. Blumberg, Jeffery T. Sample, Daniel Braun, Gilbert Lenoir, E Kieff and Ramana R. Yalamanchili. Their work appears in journals such as Journal of Virology, Proceedings of the National Academy of Sciences, Virology, The Journal of Experimental Medicine and Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.